StockData
Kestra Medical Technologies, Ltd. logo

Kestra Medical Technologies, Ltd. (KMTS) stock

KMTSNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends April 30
Financials through Q1 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 14, 2026Score 5/30
$25.10−1.53 (-5.75%)

Close on Nov 20, 2026Market cap $1.50BP/E –Yield –

Kestra Medical Technologies gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Kestra Medical Technologies's gross profit for the twelve months ending Jul 31, 2026 was $57.51M, up 99.3% year over year. For fiscal 2026 it was $48.86M, up 101.8% from the year before.

Annual gross profit

PeriodPeriod endValueChange
FY2026Apr 30, 2026$48.86M+101.8%
FY2025Apr 30, 2025$24.21M+6587.8%
FY2024Apr 30, 2024$362.00K–

Quarterly gross profit

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q1 FY2027CQ2 2026Jul 31, 2026$17.50M+97.7%
Q4 FY2026CQ1 2026Apr 30, 2026$15.68M+105.5%
Q3 FY2026CQ4 2025Jan 31, 2026$12.91M+97.1%
Q2 FY2026CQ3 2025Oct 31, 2025$11.42M+96.0%
Q1 FY2026CQ2 2025Jul 31, 2025$8.85M+110.7%
Q4 FY2025CQ1 2025Apr 30, 2025$7.63M–
Q3 FY2025CQ4 2024Jan 31, 2025$6.55M–
Q2 FY2025CQ3 2024Oct 31, 2024$5.83M–
Q1 FY2025CQ2 2024Jul 31, 2024$4.20M–

More Kestra Medical Technologies figures

See a number that looks wrong?